文献速递心脑血管急症重症综合管理与镇静镇痛

正中神经电刺激诱导急性创伤性昏迷觉醒:系统评价与Meta分析

Acute Traumatic Coma Awakening Induced by Median Nerve Electrical Stimulation: A Systematic Review and Meta-Analysis.
PubMed 文献 · Neurocrit Care · 2024-10-24
一句话结论Meta分析显示正中神经电刺激(MNES)可使TBI昏迷患者觉醒比例提高(RR 1.36),6个月时仍获益(RR 1.31),GCS提高2.38分,并发症无显著差异。

该系统评价与Meta分析检索PubMed、Embase、Ovid MEDLINE、Cochrane Library及中国知网自建库至2023年7月,纳入18项随机对照试验、共1831例TBI昏迷患者,评估正中神经电刺激(MNES)对促醒的疗效。结果显示治疗后MNES组恢复意识比例显著高于对照组(RR 1.36,95% CI 1.18-1.56;P < 0.001),伤后6个月仍显著(RR 1.31,95% CI 1.16-1.47;P < 0.001);GCS评分平均提高2.38分(95% CI 1.78-2.98;P < 0.001)。肺炎、癫痫、胃出血等并发症两组无显著差异。作者认为MNES是TBI后昏迷促醒的有效方法。

要点

  • 治疗后MNES组恢复意识比例显著高于对照组(RR 1.36,95% CI 1.18-1.56;P < 0.001)
  • 伤后6个月MNES组恢复意识比例仍显著高于对照组(RR 1.31,95% CI 1.16-1.47;P < 0.001)
  • MNES显著改善GCS评分,平均提高2.38分(95% CI 1.78-2.98;P < 0.001)
  • 两组肺炎(RR 0.86,95% CI 0.72-1.03;P = 0.107)、癫痫(RR 1.24,95% CI 0.49-3.10;P = 0.651)、胃出血(RR 1.08,95% CI 0.60-1.93;P = 0.795)无显著差异
  • 作者认为MNES是TBI后促醒的有效方法,共纳入18项随机对照试验、1831例患者

适用人群与场景

  • 创伤性脑损伤(TBI)后昏迷患者,数据来自18项随机对照试验、共1831例

处置流程与药物剂量

  • 正中神经电刺激(MNES)用于TBI后昏迷促醒;原文未给出刺激参数、频率、疗程等具体方案

研究设计与关键结果

  • 研究类型:系统评价与Meta分析,纳入18项随机对照试验,共1831例TBI患者
  • 检索数据库:PubMed、Embase、Ovid MEDLINE、Cochrane Library、中国知网,检索时间自建库至2023年7月
  • 异质性评估:采用χ2检验和I2检验;连续变量用均数差及95% CI,二分类变量用相对危险度(RR)及95% CI
  • 治疗后恢复意识比例:MNES组显著高于对照组(RR 1.36,95% CI 1.18-1.56;P < 0.001)
  • 伤后6个月恢复意识比例:MNES组显著高于对照组(RR 1.31,95% CI 1.16-1.47;P < 0.001)
  • GCS评分:MNES组较对照组平均提高2.38分(95% CI 1.78-2.98;P < 0.001)
  • 并发症:肺炎(RR 0.86,95% CI 0.72-1.03;P = 0.107)、癫痫(RR 1.24,95% CI 0.49-3.10;P = 0.651)、胃出血(RR 1.08,95% CI 0.60-1.93;P = 0.795)两组无显著差异

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,仅纳入随机对照试验
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为MNES是TBI后昏迷促醒的有效方法,可加快治疗后及伤后6个月的意识恢复,且未增加肺炎、癫痫、胃出血风险
  • 原文未给出MNES具体刺激参数与疗程,床旁实施需参照原文所纳入各试验方案
  • 适用人群为TBI后昏迷患者;其他病因昏迷不在此文结论范围内

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Traumatic brain injury (TBI) is widely recognized as a major cause of death and disability. Optimizing recovery from coma is a priority for improving patient prognosis. Recently, an increasing number of studies have demonstrated that median nerve electrical stimulation (MNES) may be a potential approach for comatose patients awakening with TBI, although the results of these studies are not consistent. The aim of this study was to evaluate the effects of the MNES on recovery from coma in patients with TBI based on data from randomized controlled trials. The PubMed, Embase, Ovid MEDLINE, Cochrane Library, and China National Knowledge Infrastructure electronic databases were systematically searched from their inception to July 2023 using specific keywords. The χ2 test and I2 test were used to evaluate the heterogeneity across these studies. The mean differences with 95% confidence intervals (CIs) and relative risk (RR) with 95% CIs were adopted to analyze the continuous outcomes and binary outcomes, respectively. A total of 1831 patients from 18 studies were included in this meta-analysis. There were significant differences in the proportions of patients who regained consciousness between the MNES group and the control group after treatment (RR 1.36, 95% CI 1.18-1.56; P < 0.001) and at 6 months after injury (RR 1.31, 95% CI 1.16-1.47; P < 0.001). MNES significantly improved the Glasgow Coma Scale score (mean difference 2.38, 95% CI 1.78-2.98; P < 0.001). Furthermore, no significant differences in complications between the two groups of patients were observed, including pneumonitis (RR 0.86, 95% CI 0.72-1.03; P = 0.107), seizures (RR 1.24, 95% CI 0.49-3.10; P = 0.651), or gastric hemorrhage (RR 1.08, 95% CI 0.60-1.93; P = 0.795).The results of the present study indicate that patients with TBI in the MNES group recovered from coma more rapidly after treatment and at 6 months after injury. These results suggest that MNES is an effective approach for coma awakening after TBI.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Yang J, Li X, Yang X, et al. Acute Traumatic Coma Awakening Induced by Median Nerve Electrical Stimulation: A Systematic Review and Meta-Analysis. Neurocrit Care. 2024. PMID: 39448428. doi:10.1007/s12028-024-02141-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。